Avantra Biosciences, a provider of proteomic and genomic products and services to the life sciences industry, has renamed to Courtagen Life Sciences.
Subscribe to our email newsletter
The company will continue to use the Avantra name for its proteomics portfolio, which includes the Avantra Biomarker System.
Courtagen CEO Brian McKernan said the name change reflects the company’s new strategic focus on developing advanced technologies in both genomic and proteomic areas and their commitment to bring additional needed technologies to the market.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.